Clinical Trial Update: Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

View source ↗

Summary

The clinical trial update reports ongoing biomarker research in patients treated with cyclophosphamide after donor allogeneic hematopoietic stem cell transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Donor | Status: ACTIVE_NOT_RECRUITING